These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 2541093)
1. ACTH and the effects of anticholinergic drugs in dystonia. Sandyk R Int J Neurosci; 1989 Mar; 45(1-2):123-6. PubMed ID: 2541093 [No Abstract] [Full Text] [Related]
2. Cholinergic pharmacology of blepharospasm with oromandibular dystonia (Meige's syndrome). Klawans HL; Tanner CM Adv Neurol; 1988; 49():443-50. PubMed ID: 3278551 [No Abstract] [Full Text] [Related]
3. ACTH and its relationship to the cataplectic syndrome. Sandyk R Int J Neurosci; 1989 Aug; 47(3-4):317-9. PubMed ID: 2553635 [No Abstract] [Full Text] [Related]
4. Paroxysmal dystonia responsive to anticholinergic drugs. Micheli F; Fernandez Pardal M; de Arbelaiz R; Lehkuniec E; Giannaula R Clin Neuropharmacol; 1987 Aug; 10(4):365-9. PubMed ID: 3503680 [TBL] [Abstract][Full Text] [Related]
5. Acute anticholinergic action in focal dystonia. Lang AE; Sheehy MP; Marsden CD Adv Neurol; 1983; 37():193-200. PubMed ID: 6134443 [TBL] [Abstract][Full Text] [Related]
6. Do the neurochemical characteristics of fibroblasts in tissue culture predict the therapeutic drug response of dystonia patients? Richardson JS; Dunlop DM Adv Neurol; 1988; 50():187-92. PubMed ID: 3400493 [No Abstract] [Full Text] [Related]
7. Dystonia: therapy with high dosage anticholinergic medication. Reddy RV; Siemers ER Indiana Med; 1987 Jun; 80(6):552-3. PubMed ID: 2886522 [No Abstract] [Full Text] [Related]
8. The predictive value of acute antimuscarinic drugs for the chronic efficacy of antimuscarinic drugs in adults with focal dystonia. Tanner CM; Wilson RS; Goetz CG; Shannon KM Adv Neurol; 1988; 50():557-60. PubMed ID: 3400510 [No Abstract] [Full Text] [Related]
10. Cognitive processes in idiopathic dystonia treated with high-dose anticholinergic therapy: implications for treatment strategies. Taylor AE; Lang AE; Saint-Cyr JA; Riley DE; Ranawaya R Clin Neuropharmacol; 1991 Feb; 14(1):62-77. PubMed ID: 2029694 [TBL] [Abstract][Full Text] [Related]
11. Delayed extinction of executive sets associated with decreased cholinergic function: a mechanism of perseverative and intrusive behavior. Galdi JA Brain Cogn; 1993 May; 22(1):1-18. PubMed ID: 8098943 [TBL] [Abstract][Full Text] [Related]
12. High-dosage anticholinergic therapy in dystonia. Fahn S Adv Neurol; 1983; 37():177-88. PubMed ID: 6134442 [TBL] [Abstract][Full Text] [Related]
13. Co-release of ACTH and beta-endorphin immunoreactivity in human subjects in response to central cholinergic stimulation. Risch SC; Kalin NH; Janowsky DS; Cohen RM; Pickar D; Murphy DL Science; 1983 Oct; 222(4619):77. PubMed ID: 6312560 [No Abstract] [Full Text] [Related]
14. Animal models of neuroleptic-induced acute dystonia. Stewart BR; Rupniak NM; Jenner P; Marsden CD Adv Neurol; 1988; 50():343-59. PubMed ID: 2899952 [No Abstract] [Full Text] [Related]
15. [Advances in the treatment of the dystonias]. Giménez-Roldán S Arch Neurobiol (Madr); 1991; 54(5):198-205. PubMed ID: 1804033 [TBL] [Abstract][Full Text] [Related]
16. [Advances in the treatment of the dystonias]. Giménez-Roldán S Arch Neurobiol (Madr); 1991; 54 Suppl 3():32-9. PubMed ID: 1810206 [TBL] [Abstract][Full Text] [Related]
17. Systemic therapy of dystonia. Fahn S Can J Neurol Sci; 1987 Aug; 14(3 Suppl):528-32. PubMed ID: 3315156 [TBL] [Abstract][Full Text] [Related]